Skip to main content
. 2022 Jun 3;13:875695. doi: 10.3389/fphar.2022.875695

FIGURE 3.

FIGURE 3

Representative images of treated area in mice at day five after treatment with (A) trabectedin (grade 3), (B) trabectedin and hyaluronidase (grade 3), (C) trabectedin and tacrolimus (grade 2), (D) trabectedin and DMSO (grade 2). (E) Extent of skin changes assessed by grading. (F) Size of affected skin area in lesions graded at least as grade 2, statistically analyzed using ANOVA followed by a post-hoc test with a Tukey-B correction *p < 0.05, ***p < 0.005, ns = not significant. Scale bar is 1 cm.